Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
07/29/2014 | US8790934 Nanoparticles |
07/29/2014 | US8790925 Methods of generating hyper iNOS expressing cells and uses thereof |
07/29/2014 | US8790922 RNA sequence-specific mediators of RNA interference |
07/29/2014 | US8790724 Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care |
07/29/2014 | US8790723 Eutectic-based self-nanoemulsified drug delivery system |
07/29/2014 | US8790714 Compositions and methods for treatment and prevention of osteoarthritis |
07/29/2014 | US8790702 Modified hyaluronic acid polymer compositions and related methods |
07/29/2014 | US8790700 Modified release formulations containing drug-ion exchange resin complexes |
07/29/2014 | US8790695 Medicinal carriers, and preparation method and uses thereof |
07/29/2014 | US8790694 Gastric retentive extended release pharmaceutical compositions |
07/29/2014 | US8790691 Modified drugs for use in liposomal nanoparticles |
07/29/2014 | US8790689 Tamper resistant transdermal dosage form |
07/29/2014 | US8790687 Triterpene compounds which are effective on improvement of brain function |
07/29/2014 | US8790686 Method and composition for treating hemorrhoids |
07/29/2014 | US8790675 Biocide compositions comprising carbamates |
07/29/2014 | US8790674 Derivative for preparing a topical veterinary pharmaceutical composition for combating external parasites |
07/29/2014 | US8790655 Conjugates of synthetic TLR agonists and uses therefor |
07/29/2014 | US8790654 Glycosylceramide adjuvant for saccharide antigens |
07/29/2014 | US8790646 Compositions and methods for modulating vascular development |
07/29/2014 | US8790634 MetAP-2 inhibitor polymersomes for therapeutic administration |
07/29/2014 | US8790633 Polymer coated magnetic particles |
07/29/2014 | US8790632 Polymer-based tissue-adhesive form medical use |
07/29/2014 | US8790631 Use of biocompatible polymers for the preparation of a composition or a medical device |
07/29/2014 | CA2806767C Patch and method for producing the same |
07/29/2014 | CA2697205C Peptidomimetic protease inhibitors |
07/29/2014 | CA2685845C Liquorice extract antimicrobial and anti-inflammatory isolates |
07/29/2014 | CA2685270C Expression vectors for stimulating an immune response and methods of using the same |
07/29/2014 | CA2677061C Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
07/29/2014 | CA2673683C Compounds and method for treatment of cancer |
07/29/2014 | CA2667547C Piperidyl-propane-thiol ccr3 modulators |
07/29/2014 | CA2662510C Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy |
07/29/2014 | CA2661819C Fixed combination dosage forms for the treatment of migraine |
07/29/2014 | CA2655398C 4-amino-3-(3-azolyl-phenoxymethyl)-thieno[3,2-c]pyridine-7-carboxylic acid derivatives and uses thereof for treating cancer, atherosclerosis and restenosis |
07/29/2014 | CA2653660C Sulphated hyaluronic acid for treating degenerative osteoarthritis |
07/29/2014 | CA2653223C Therapeutic pyrrolidine compounds |
07/29/2014 | CA2652500C Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
07/29/2014 | CA2650057C Phenyl- or pyridinyl-amide as inhibitors of c-fms kinase |
07/29/2014 | CA2646942C Improved snuff composition |
07/29/2014 | CA2641421C Small molecule inhibitors of pdz interactions |
07/29/2014 | CA2637768C Benzamide and heteroarene derivatives |
07/29/2014 | CA2637243C Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product |
07/29/2014 | CA2635047C Novel thiophene derivatives as s1p1/edg1 receptor agonists |
07/29/2014 | CA2634743C Modified lysine-mimetic compounds |
07/29/2014 | CA2634701C Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammation |
07/29/2014 | CA2627211C Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors |
07/29/2014 | CA2623304C Medicine, food and drink or feed containing sphingomyelin |
07/29/2014 | CA2621273C Stable pharmaceutical composition comprising a pyrimidine-sulfamide |
07/29/2014 | CA2618641C Cyclopropyl compounds and compositions for delivering active agents |
07/29/2014 | CA2611724C Stabilized milnacipran formulation |
07/29/2014 | CA2608631C Method and composition for treating inflammatory disorders |
07/29/2014 | CA2606933C Steroid kit and foamable composition and uses thereof |
07/29/2014 | CA2602328C Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
07/29/2014 | CA2593993C Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases |
07/29/2014 | CA2564603C Therapeutic compositions containing at least one pyrrolobenzodiazepine derivative and fludarabine |
07/29/2014 | CA2562554C Thio-substituted arylmethanesulfinyl derivatives |
07/29/2014 | CA2558112C Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein |
07/29/2014 | CA2555507C Use of proton pump inhibitors for the treatment of cancer conditions |
07/29/2014 | CA2541405C The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin |
07/29/2014 | CA2473289C Asymmetric urea compounds useful as naaladase and psma imaging agents |
07/29/2014 | CA2463772C Thrombin-cleavable chimeric proteins |
07/29/2014 | CA2449713C Calcium phosphate delivery vehicles for osteoinductive proteins |
07/24/2014 | WO2014113814A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
07/24/2014 | WO2014113794A2 Oligooxopiperazines for p53 reactivation |
07/24/2014 | WO2014113784A1 Compounds, extracts and methods from chinese medicinal herb sophora flavescens that inhibit airway contraction |
07/24/2014 | WO2014113750A1 Novel ddp-iv inhibitors |
07/24/2014 | WO2014113700A1 Pharmaceutical compositions comprising nitroxyl donors |
07/24/2014 | WO2014113696A1 Nitroxyl donors with improved therapeutic index |
07/24/2014 | WO2014113675A1 Antiviral compounds and methods of use thereof |
07/24/2014 | WO2014113638A1 Multi-use albuterol maintenance therapy formulations and devices therefor |
07/24/2014 | WO2014113635A1 Reduction of toxicities by synthetic panaxytriol analogs |
07/24/2014 | WO2014113634A1 Toll-like receptor 2-agonistic lipopeptides, and method of making the same |
07/24/2014 | WO2014113616A1 Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl) methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and its crystalline |
07/24/2014 | WO2014113609A1 Stable indole-3-propionate salts of s-adenosyl-l-methionine |
07/24/2014 | WO2014113607A1 Protective molecules against anthrax toxin |
07/24/2014 | WO2014113564A1 New itch treatment using a combination of neurokinin-1, gastrin releasing peptide, and glutamate receptor antagonists |
07/24/2014 | WO2014113540A1 A deep intronic target for splicing correction on spinal muscular atrophy gene |
07/24/2014 | WO2014113495A1 Activation or reactivation of ache |
07/24/2014 | WO2014113485A1 Lysophosphatidic acid receptor antagonists |
07/24/2014 | WO2014113467A1 Stat3 inhibitor |
07/24/2014 | WO2014113429A2 Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith |
07/24/2014 | WO2014113427A2 Irciniastatin analogues |
07/24/2014 | WO2014113413A1 Bcl-2bcl-xl inhibitors and therapeutic methods using the same |
07/24/2014 | WO2014113406A1 Compositions and methods for treating pancreatic cancer |
07/24/2014 | WO2014113404A1 Treating pulmonary conditions |
07/24/2014 | WO2014113388A1 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors |
07/24/2014 | WO2014113377A1 Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant |
07/24/2014 | WO2014113357A1 Combinations of a glp1r agonist and metformin and use thereof for the treatment of type 2 diabetes and other disorders |
07/24/2014 | WO2014113303A1 4-fluoropiperidine orexin receptor antagonists |
07/24/2014 | WO2014113260A1 Androgen receptor modulator and uses thereof |
07/24/2014 | WO2014113191A1 Hedgehog pathway signaling inhibitors and therapeutic applications thereof |
07/24/2014 | WO2014113048A1 Compositions and methods for diagnosing and treating sepsis |
07/24/2014 | WO2014112955A1 Use of selective delta-opioid receptor antagonists and specific sensory receptor ligands |
07/24/2014 | WO2014112861A1 An antiviral pharmaceutical composition |
07/24/2014 | WO2014111957A1 Nitric oxide releasing prodrugs of therapeutic agents |
07/24/2014 | WO2014111955A1 Fingolimod containing stable composition |
07/24/2014 | WO2014111954A1 Process for the preparation and purification of apixaban |
07/24/2014 | WO2014111871A1 4,5-dihydroisoxazole derivatives as nampt inhibitors |
07/24/2014 | WO2014111839A1 Pyrrole derivatives as alpha 7 nachr modulators |
07/24/2014 | WO2014111838A1 Use of alpha 7 nicotinic acetylcholine receptor agonists |
07/24/2014 | WO2014111837A1 Use of alpha 7 nicotinic acetylcholine receptor agonists |